# Bainian Yihao

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bainian-yihao

- Industry: Biotechnology
- Headquarters: Chengdu, China
- Total disclosed funding: $22M
- Latest round: Series A (Apr 8, 2019)
- Investors on record: 2

## About

Based in Chengdu, China and established in 2017, Bainian Yihao is a bio-pharmaceutical company which mainly develops drugs for CAR-T cell therapy, tumor vaccine, immunological therapy,gene therapy, and small molecule targeted drugs.

## Funding rounds

- Series A, Apr 8, 2019, $22M — Detong Capital, PKU V-Ming Investment

## Investors

- Detong Capital (https://capitalatlas.ai/funds/detong-capital) — Series A
- PKU V-Ming Investment (https://capitalatlas.ai/funds/pku-v-ming-investment) — Series A
